Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Fortrea Clinical Research Unit, Daytona Beach, Florida Fortrea Clinical Research Unit, Dallas, Texas Fortrea Clinical Research Unit, Madison, Wisconsin